NK cell-based immunotherapy for malignant diseases | Cellular & Molecular Immunology
Issels Immuno-Oncology - LAK Cell Therapy for the Treatment of Cancer
Cells | Free Full-Text | Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions
Frontiers | Next Generation Natural Killer Cells for Cancer Immunotherapy
Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy | ACS Applied Materials & Interfaces
Natural killer (NK) and lymphokine-activated killer (LAK) cell functions from healthy dogs and 29 dogs with a variety of spontaneous neoplasms | springermedizin.de
AAAAI
Relationship between Psychoncology and Psychoneuroendocrinoimmunology (PNEI): Enhanced T-Regulatory Lymphocyte Activity in Cancer Patients with Self-punishement, Evaluated by Rorschach Test | In Vivo
A Combined Lymphokine-activated Killer (LAK) Cell Immunotherapy and Adenovirus-p53 Gene Therapy for Head and Neck Squamous Cell Carcinoma | Anticancer Research
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy: Molecular Therapy - Oncolytics
Natural Killer Cells | Clinical Gate
Frontiers | All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity
How Monoclonal Antibodies are Changing the Face of Immunotherapy | MyBioSource Learning Center
Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studies. - Abstract - Europe PMC
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity | Journal for ImmunoTherapy of Cancer
Cytokine-induced killer (CIK) cells: from basic research to clinical translation | Cancer Communications | Full Text
Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.
Cell-based immunotherapy
Lymphokine-Activated Killer Cells: Biology and Relevance to Disease: Cancer Investigation: Vol 11, No 4
Innate or non-specific immunity
Frontiers | In vitro models to study natural killer cell dynamics in the tumor microenvironment
Pharmacological targeting of natural killer cells for cancer immunotherapy - Miyazato - 2020 - Cancer Science - Wiley Online Library
Antigen-independent killer cells prepared for adoptive immunotherapy: One source, divergent protocols, diverse nomenclature - ScienceDirect
The immunomodulatory effects of gentamicin, imipenem, piperacillin and amphotericin B on LAK effector function in vitro1
